Nabla, a Paris- and New York-based startup renowned for its artificial intelligence-powered copilot for medical professionals, has raised a Series C funding round led by HV Capital, with Highland Europe, DST Global, and existing investors such as Cathay Innovation and Tony Fadell´s Build Collective participating. While the precise monetary figures for the latest round are undisclosed, this investment brings Nabla´s aggregate raised capital since its 2018 launch to an unspecified new high.
The company has experienced dramatic growth in recent months, citing a fivefold increase in revenue over the past six months and a user base now exceeding 85,000 clinicians. Nabla’s artificial intelligence assistant is presently deployed in over 130 healthcare organizations. The tool automates the creation of medical reports and clinical notes on behalf of staff, sharply reducing administrative burdens. Company claims indicate over a 50% reduction in clinical documentation time, with associated benefits including lower clinician burnout and higher patient satisfaction.
With its new funding, Nabla plans to widen its focus from documentation automation to building a comprehensive Adaptive Agentic Platform. This includes features like a real-time coding assistant that detects billing issues and improves documentation as care unfolds, a ´context-aware agent´ capable of surfacing historical patient data and taking actions directly within electronic health records, and enhanced toolkits for nurses and inpatient teams. These developments come against a backdrop of surging venture investment in artificial intelligence startups, both in the United States—where roughly half of all funding has gone to artificial intelligence-driven companies in the past year—and globally, with the sector representing a majority share of early 2025 deals by both volume and value. Nabla´s continued expansion signals growing confidence in artificial intelligence´s ability to streamline complex clinical processes and reshape healthcare delivery.
